Skip to main content
. Author manuscript; available in PMC: 2020 Jan 31.
Published in final edited form as: Ann Thorac Surg. 2018 Sep 15;107(1):277–284. doi: 10.1016/j.athoracsur.2018.07.033

Table 3.

Oncologic outcomes

Variables Induction chemotherapy only (N=662) Induction chemo-radiation (N=160) P value
Recurrence 310(46.8) 82(51.6) 0.282
Recurrence pattern 0.891
   None 352(53.2) 77(50.0)
   Local 15(9.7)
   Distant 65(9.8) 51(33.1)
   Local and Distant 201(30.4) 11(7.1)
43(6.5)
Overall survival (%) 0.250
   3-year rate 51.7 57.2
   5-year rate 39.9 42.9
   Median survival time, months 37.5 48.0
Disease-free survival (%) 0.207
   3-year rate 35.3 44.6
   5-year rate 28.7 29.8
   Median survival time, months 19.6 30.1
Patients with mediastinal staging (N=404) (N=151)
Overall survival (%) 0.341
   3-year rate 53.3 57.9
   5-year rate 41.5 43.8
   Median survival time, months 39.9 48.2
Disease-free survival (%) 0.455
   3-year rate 38.2 46.1
   5-year rate 29.9 30.5
   Median survival time, months 21.5 31.2

Note: Data are no. of patients (%) unless otherwise indicated.